Stockscreener 앱 받기
2.02
5.16%
-0.11
Neumora Therapeutics Inc 주식(NMRA)의 최신 뉴스
Volume Report: Is Neumora Therapeutics Inc showing insider buying2025 Fundamental Recap & Weekly Return Optimization Alerts - baoquankhu1.vn
Earnings Beat: Should I hold or sell SPCE nowMarket Weekly Review & Fast Gain Stock Trading Tips - baoquankhu1.vn
RSI Check: Is Neumora Therapeutics Inc benefiting from innovation trends2025 Short Interest & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Aug Wrap: Is Castle Biosciences Inc vulnerable to short sellersVolume Spike & Breakout Confirmation Alerts - baoquankhu1.vn
Why Neumora Therapeutics Inc stock appeals to analystsProduct Launch & Smart Allocation Stock Reports - Bộ Nội Vụ
Neumora Therapeutics (NASDAQ:NMRA) Upgraded at Leerink Partnrs - MarketBeat
Leerink Partners Initiates Coverage of Neumora Therapeutics (NMRA) with Outperform Recommendation - Nasdaq
Leerink Partners Begins Coverage on Neumora Therapeutics (NASDAQ:NMRA) - MarketBeat
Leerink Initiates Neumora Therapeutics at Outperform With $8 Price Target - marketscreener.com
Neumora outlines 2026 neuroscience pipeline and obesity plans - TipRanks
Neumora Therapeutics, Inc. Presents at J.P. Morgan Healthcare Conference - TradingView — Track All Markets
Diversified CNS Pipeline and NLRP3 Opportunity Drive Upside in Neumora: Justifying an Outperform/Buy Rating - TipRanks
Leerink Partners initiates coverage on Neumora stock with Outperform rating By Investing.com - Investing.com Canada
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Is Neumora Therapeutics Inc. stock a defensive play in 2025Gap Down & Advanced Technical Analysis Signals - Улправда
Published on: 2026-01-12 18:50:31 - ulpravda.ru
Neumora Therapeutics touts Phase 1B NMRA-511 gains in Alzheimer’s agitation, eyes higher doses - MarketBeat
Neumora gains after early-stage trial results for Alzheimer’s product - MSN
Trend Review: What hedge fund activity signals for Neumora Therapeutics Inc. stockJuly 2025 Sector Moves & Weekly Chart Analysis and Guides - Улправда
Can Neumora Therapeutics Inc. stock beat market expectations this quarterVolume Analysis Techniques & Turn Data into Profits With Our Strategies - Улправда
Mizuho reiterates Outperform rating on Neumora Therapeutics stock By Investing.com - Investing.com Canada
Analysts Are Bullish on These Healthcare Stocks: Fortrea Holdings Inc. (FTRE), DENTSPLY SIRONA (XRAY) - The Globe and Mail
Neumora outlines 2026 pipeline milestones for neuroscience programs By Investing.com - Investing.com Nigeria
Positive Risk-Reward on Neumora as NMRA-511 Emerges as a Differentiated Therapy for Alzheimer’s Agitation, Supporting Buy Rating and $18 Target - TipRanks
Mizuho raises Neumora Therapeutics stock price target on positive trial data - Investing.com Canada
Neumora shares climb after encouraging Phase 1b results for Alzheimer’s agitation therapy - MSN
Why Is Neumora Therapeutics Stock Gaining Monday?Neumora Therapeutics (NASDAQ:NMRA) - Benzinga
Neumora stock rises after positive Phase 1b data for Alzheimer’s agitation drug - Investing.com Nigeria
Neumora stock rises after positive Phase 1b data for Alzheimer’s agitation drug By Investing.com - Investing.com South Africa
NMRA Surges On Clinically Meaningful Results In Phase 1 Alzheimer's Disease Agitation Study - Nasdaq
Neumora outlines 2026 pipeline milestones for neuroscience programs - Investing.com
Neumora posts trial results for Alzheimer’s drug (NMRA:NASDAQ) - Seeking Alpha
Neumora Therapeutics Reports Encouraging Phase 1b Data For NMRA-511 In Alzheimer's Disease Agitation - Nasdaq
Neumora reports promising Phase 1b results in Alzheimer’s agitation - TipRanks
Neumora Therapeutics Announces Positive Phase 1b Study Results for NMRA-511 - TradingView — Track All Markets
Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones - The Manila Times
Neumora Therapeutics Announces Positive Results from NMRA-511 Phase 1b Signal-Seeking Study in Alzheimer’s Disease Agitation - The Manila Times
New Alzheimer’s treatment candidate eases agitation in early study - Stock Titan
10 Best New Penny Stocks to Invest In - Insider Monkey
RBC Sees Upside Potential in Neumora Therapeutics (NMRA) - Finviz
What analysts say about Neumora Therapeutics Inc stockMid Cap Growth Trends & Free Superior Trading Gains - earlytimes.in
Momentum Shift: Will Neumora Therapeutics Inc. stock benefit from AI adoptionNew Guidance & Consistent Income Trade Recommendations - moha.gov.vn
Cash Runway Looks Solid, But Is Neumora's Pipeline Ready To Deliver? - RTTNews
Is Neumora Therapeutics Inc. stock resilient to inflation2025 Volatility Report & Fast Gaining Stock Reports - Улправда
Will Neumora Therapeutics Inc. stock benefit from AI adoptionOil Prices & Weekly Setup with High ROI Potential - Улправда
Analyst Calls: How Neumora Therapeutics Inc stock reacts to job market dataIPO Watch & Smart Swing Trading Techniques - moha.gov.vn
Will Neumora Therapeutics Inc. stock beat EPS estimates2025 EndofYear Setup & Risk Controlled Stock Pick Alerts - DonanımHaber
4.73%
0.92%
자본화:
|
볼륨(24시간):